FRM
SWAV

Fox Run Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Fox Run Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,304
Closed -$630K – 1131
2023
Q4 		$630K Buy
+3,304
New +$624K 0.16% 216
2023
Q2 		– Sell
-3,423
Closed -$742K – 1028
2023
Q1 		$742K Buy
3,423
+938
+38% +$183K 0.24% 121
2022
Q4 		$511K Buy
+2,485
New +$628K 0.21% 169

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fox Run Management's SWAV Position: Q1 2024 in Review

Fox Run Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 3,304 shares — an estimated $630K sold.

Fox Run Management first reported a position in SWAV in Q4 2022 and held it in 3 quarters. The position peaked at $742K in Q1 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Fox Run Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fox Run Management sold 3,304 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $630K.
  • Fox Run Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Fox Run Management's Shockwave Medical, Inc. Common Stock position peaked at $742K in Q1 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Fox Run Management's 13F filing for Q1 2024, filed 13 May 2024.